Khalid Bashir Mir

Par-4 activation restrains EMT-induced chemoresistance in PDAC by attenuating MDM-2

Syed Mudabir Ahmad, Debasis Nayak, Khalid Bashir Mir et al. · Pancreatology · 2020 · 21 citations

Signal Transduction, Par-4 Activation, Medicine +5

Rottlerin promotes anti-metastatic events by ameliorating pharmacological parameters of paclitaxel: An in-vivo investigation in the orthotopic mouse model of breast cancer

Diksha Manhas, Khalid Bashir Mir, Nancy Tripathi et al. · Chemico-Biological Interactions · 2022 · 17 citations

Oncology, Medicine, Anti-metastatic Events +8

Isolation and anticancer activity evaluation of rare Bisaryl anthraquinone antibiotics from novel Streptomyces sp. strain of NW Himalayan region

Ravi S. Manhas, Syed Mudabir Ahmad, Khalid Bashir Mir et al. · Chemico-Biological Interactions · 2022 · 12 citations

Medicinal Chemistry, Antimicrobial Susceptibility, Antibiotics +11

Quinoxalinone substituted pyrrolizine (4h)-induced dual inhibition of AKT and ERK instigates apoptosis in breast and colorectal cancer by modulating mitochondrial membrane potential

Tanzeeba Amin, Rajneesh Paul Sharma, Khalid Bashir Mir et al. · European Journal of Pharmacology · 2023 · 12 citations

Oncology, Mitochondrial Function, Dual Inhibition +10

β-(4-fluorobenzyl) Arteannuin B induced interaction of ATF-4 and C/EBPβ mediates the transition of breast cancer cells from autophagy to senescence

Khalid Bashir Mir, Mir Mohd Faheem, Syed Mudabir Ahmad et al. · Frontiers in Oncology · 2022 · 10 citations · Full text